Literature DB >> 9503277

Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan. Short communication.

A Yoritaka1, N Hattori, H Yoshino, Y Mizuno.   

Abstract

We report -108Met/Val polymorphism of the COMT gene in Japanese patients with Parkinson's disease (PD). The allele frequency for -108Val was higher in PD patients compared with controls, although the differences did not reach the statistical significance. However, the frequency of -108Val homozygotes was significantly higher in PD patients (56.8%) than in control subjects (44.2%), and heterozygotes of -108Met/Val were less in PD. COMT gene polymorphism may constitute a genetic risk factor for PD among Japanese.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9503277     DOI： 10.1007/BF01294732

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  13 in total

1.  Possible role for COMT in psychosis associated with velo-cardio-facial syndrome.

Authors:  I Dunham; J Collins; R Wadey; P Scambler
Journal:  Lancet       Date:  1992-11-28       Impact factor: 79.321

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase.

Authors:  F Hoda; D Nicholl; P Bennett; M Arranz; K J Aitchison; A al-Chalabi; H Kunugi; H Vallada; P N Leigh; K R Chaudhuri; D A Collier
Journal:  Biochem Biophys Res Commun       Date:  1996-11-21       Impact factor: 3.575

4.  Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder.

Authors:  M Karayiorgou; M Altemus; B L Galke; D Goldman; D L Murphy; J Ott; J A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

5.  Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans.

Authors:  H L McLeod; L Fang; X Luo; E P Scott; W E Evans
Journal:  J Pharmacol Exp Ther       Date:  1994-07       Impact factor: 4.030

6.  Human catechol-O-methyltransferase: cloning and expression of the membrane-associated form.

Authors:  B Bertocci; V Miggiano; M Da Prada; Z Dembic; H W Lahm; P Malherbe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Electrophoretic analysis of low and high activity forms of catechol-O-methyltransferase in human erythrocytes.

Authors:  M H Grossman; C Szumlanski; J B Littrell; R Weinstein; R M Weinshilboum
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

8.  Difference in erythrocyte catechol-O-methyltransferase activity between Orientals and Caucasians: difference in levodopa tolerance.

Authors:  L Rivera-Calimlim; D K Reilly
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

9.  Expression of enzymatically active rat liver and human placental catechol-O-methyltransferase in Escherichia coli; purification and partial characterization of the enzyme.

Authors:  K Lundström; C Tilgmann; J Peränen; N Kalkkinen; I Ulmanen
Journal:  Biochim Biophys Acta       Date:  1992-01-06

10.  Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis.

Authors:  K Jellinger; E Kienzl; G Rumpelmair; P Riederer; H Stachelberger; D Ben-Shachar; M B Youdim
Journal:  J Neurochem       Date:  1992-09       Impact factor: 5.372
View more
  5 in total

1.  Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.

Authors:  Lixue Chuan; Jie Gao; Yuying Lei; Raoxiang Wang; Lechun Lu; Xianyu Zhang
Journal:  Neurol Sci       Date:  2014-07-25       Impact factor: 3.307

2.  Genetic Polymorphisms of Pharmacogenes among the Genetically Isolated Circassian Subpopulation from Jordan.

Authors:  Laith N Al-Eitan; Doaa M Rababa'h; Nancy M Hakooz; Mansour A Alghamdi; Rana B Dajani
Journal:  J Pers Med       Date:  2020-01-06

3.  Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Hiroyuki Shimada; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  BMC Neurol       Date:  2011-07-25       Impact factor: 2.474

4.  Low enzymatic activity haplotypes of the human catechol-O-methyltransferase gene: enrichment for marker SNPs.

Authors:  Andrea G Nackley; Svetlana A Shabalina; Jason E Lambert; Mathew S Conrad; Dustin G Gibson; Alexey N Spiridonov; Sarah K Satterfield; Luda Diatchenko
Journal:  PLoS One       Date:  2009-04-13       Impact factor: 3.240

5.  Polymorphism of the COMT, MAO, DAT, NET and 5-HTT Genes, and Biogenic Amines in Parkinson's Disease.

Authors:  Jolanta Dorszewska; Michal Prendecki; Anna Oczkowska; Agata Rozycka; Margarita Lianeri; Wojciech Kozubski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.